相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas
Toral Patel et al.
NEUROSURGERY (2018)
Survival improvements with adjuvant therapy in patients with glioblastoma
Dasantha Jayamanne et al.
ANZ JOURNAL OF SURGERY (2018)
Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas
Biqi Zhang et al.
NEURO-ONCOLOGY (2017)
Diffuse Infiltrating Oligodendroglioma and Astrocytoma
Martin J. van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
Martin J. van den Bent et al.
LANCET (2017)
Reducing radiation dose to normal brain through a risk adapted dose reduction protocol for patients with favourable subtype anaplastic glioma
M. Back et al.
RADIATION ONCOLOGY (2017)
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
Ovidiu C. Andronesi et al.
CLINICAL CANCER RESEARCH (2016)
Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis
Vincent Dunet et al.
NEURO-ONCOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy
Federico Pessina et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma
Roshan Karunamuni et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma
Changho Choi et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Maximizing safe resection of low- and high-grade glioma
Shawn L. Hervey-Jumper et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion
Tomohiro Kawaguchi et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Brigitta G. Baumert et al.
LANCET ONCOLOGY (2016)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Radiological and Pathological Features Associated with IDH1-R132H Mutation Status and Early Mortality in Newly Diagnosed Anaplastic Astrocytic Tumours
Jason K. Wasserman et al.
PLOS ONE (2015)
IDH Mutation in Glioma: New Insights and Promises for the Future
Zorbey Turkalp et al.
JAMA NEUROLOGY (2014)
Cost-utility of maximal safe resection of WHO grade II gliomas within eloquent areas
Juan Martino et al.
ACTA NEUROCHIRURGICA (2013)
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
Gregory Cairncross et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
Martin J. van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Cost-Effectiveness Analysis of Amino Acid PET-Guided Surgery for Supratentorial High-Grade Gliomas
Alexander Heinzel et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
M. J. van den Bent et al.
LANCET ONCOLOGY (2011)
PET for radiation treatment planning of brain tumours
Anca-L. Grosu et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glioma extent of resection and its impact on patient outcome
Nader Sanai et al.
NEUROSURGERY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors
Stephanie E. Combs et al.
RADIOTHERAPY AND ONCOLOGY (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study
M Klein et al.
LANCET (2002)
Prospective Randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: Initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study
E Shaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
